27
Participants
Start Date
March 31, 2021
Primary Completion Date
June 15, 2021
Study Completion Date
June 28, 2021
BR9003 2mg
After fasting for at least 10 hours from 10:00 p.m. the previous day, one BR9003 tablet will be administered orally with 150mL of water around 8:30 a.m. after starting breakfast 30 minutes before the scheduled time of administration and finishing it.
BR9003A 1mg
After fasting for at least 10 hours from 10:00 p.m. the previous day, one BR9003A tablet will be administered orally with 150mL of water around 8:30 a.m. after starting breakfast 30 minutes before the scheduled time of administration and finishing it. Another BR9003A tablet will be administered orally with water 150mL around 20:30 after dinner between 18-19:00.
Inha University Hospital, Incheon
Lead Sponsor
Boryung Pharmaceutical Co., Ltd
INDUSTRY